Invokamet 150 mg / 1000 mg – DIN 02455455
Invokamet is Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg (tablet), sold in Canada. It is used for type 2 diabetes. It is supplied by Janssen Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg
- Brand
- Invokamet
- Strength
- Canagliflozin 150 mg / Metformin Hydrochloride 1000 mg
- Used for
- Type 2 diabetes
- Form
- Tablet
- Manufacturer
- Janssen Inc
- Drug class
- Diabetes medicine (SGLT2 inhibitor)
- Sold in
- Canada
- DIN
- 02455455
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Canagliflozin and Metformin used for?
Canagliflozin and Metformin is used for type 2 diabetes.
- Medicine type
- Diabetes medicine (SGLT2 inhibitor); diabetes medicine (biguanide)
Official uses from the US prescribing label
INVOKAMET
INVOKAMET is a combination of canagliflozin and metformin HCl immediate-release indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.
INVOKAMET XR
INVOKAMET XR is a combination of canagliflozin and metformin HCl extended-release indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus.
Canagliflozin
Canagliflozin, when used as a component of INVOKAMET or INVOKAMET XR, is indicated in adults with type 2 diabetes mellitus to reduce the risk of:
- Major adverse cardiovascular events (cardiovascular death, nonfatal myocardial infarction and nonfatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease (CVD).
- End-stage kidney disease (ESKD), doubling of serum creatinine, cardiovascular (CV) death, and hospitalization for heart failure in adults with type 2 diabetes mellitus and diabetic nephropathy with albuminuria greater than 300 mg/day.
Limitations of Use
INVOKAMET or INVOKAMET XR are not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.
From the FDA-approved label on DailyMed (published Aug 25, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02455455.
- It names Invokamet, Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Invokamet by Janssen Inc.
In Canada: prescription only.
Ingredients
Active: Canagliflozin, Metformin Hydrochloride
Other Canagliflozin and Metformin pills
- CM 611 Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg Purple, oval, 22 mm Used for type 2 diabetes
- CM4 Canagliflozin and Metformin Hydrochloride 150 mg / 1000 mg Brown, oval, 22 mm Used for type 2 diabetes
- CM 215 Canagliflozin and Metformin Hydrochloride 150 mg / 500 mg Yellow, oval, 18 mm Used for type 2 diabetes
- CM2 Canagliflozin and Metformin Hydrochloride 150 mg / 500 mg Orange, oval, 21 mm Used for type 2 diabetes
- CM 551 Canagliflozin and Metformin Hydrochloride 50 mg / 1000 mg Brown, oval, 21 mm Used for type 2 diabetes
- CM3 Canagliflozin and Metformin Hydrochloride 50 mg / 1000 mg Pink, oval, 22 mm Used for type 2 diabetes
- CM 155 Canagliflozin and Metformin Hydrochloride 50 mg / 500 mg White, oval, 17 mm Used for type 2 diabetes
- CM1 Canagliflozin and Metformin Hydrochloride 50 mg / 500 mg White, oval, 21 mm Used for type 2 diabetes